- ホーム
- > 洋書
- > 英文書
- > Nature / Ecology
Full Description
Originally published in 1999 The Commercial Use of Biodiversity examines how biodiversity and the genetic material it contains are now as valuable resources. Access to genetic resources and their commercial development involve a wide range of parties such as conservation and research institutes, local communities, government agencies and companies. Equitable partnerships are not only crucial to conservation and economic development but are also in the interests of business and often required by law.
In this authoritative and comprehensive volume, the authors explain the provisions of the Convention on Biological Diversity on access and benefit-sharing, the effect of national laws to implement these, and aspects of typical contracts for the transfer of materials. They provide a unique sector-by-sector analysis of how genetic resources are used, the scientific, technological and regulatory trends and the different markets in Pharmaceuticals, Botanical Medicines, Crop Development, Horticulture, Crop Protection, Biotechnology (in fields other than healthcare and agriculture) and Personal Care and Cosmetics Products.
This will be an essential sourcebook for all those in the commercial chain, from raw material collection to product discovery, development and marketing, for governments and policy-makers drafting laws on access and for all the institutions, communities and individuals involved in the conservation, use, study and commercialisation of genetic resources.
Contents
List of Boxes, Figures and Tables Acronyms and Abbreviations Foreword Acknowledgments 1. Introduction 2. Regulation Access to Genetic Resources and Benefit-Sharing: The Legal Aspects 3. Natural Products and the Pharmaceutical Industry 4. The Botanical Medicine Industry 5. The Development of Major Crops by the Seed Industry 6. Horticulture 7. Crop Protection 8. Biotechnology in Fields Other Than the Healthcare and Agriculture 9. The Natural Personal Care and Cosmetics Industry 10. Industry and the CBD 11. Conclusions 12. Recommendations Appendix A: The Influence of Natural Products on 1997 Pharmaceutical Sales Figures Appendix B: Scientific and Common Names of Selected Botanical Medicines Appendix C: Regulatory Frameworks for Botanical Medicines Appendix D: Tentative List of Crops Under Negotiation as the Scope of the Multilateral System in the Revised International Undertaking Appendix E: Regulatory Frameworks Relevant to the Release of Crop Varieties Useful Contacts and Sources of Information Glossary Bibliography Research Methodology and Team Index
